NRGSX | VRSGX | NRGSX / VRSGX | |
Total Expense Ratio | 0.74 | 1.00 | 74% |
Annual Report Gross Expense Ratio | 0.74 | 1.00 | 74% |
Fund Existence | 13 years | 8 years | - |
Gain YTD | -2.862 | -15.594 | 18% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.89B | 1.7B | 523% |
Annual Yield % from dividends | 0.06 | 0.00 | - |
Returns for 1 year | -6.97 | -22.89 | 30% |
Returns for 3 years | 12.34 | -16.37 | -75% |
Returns for 5 years | 7.76 | -42.50 | -18% |
Returns for 10 years | 17.91 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 91.08 | 0.87 | +0.96% |
Invesco Pharmaceuticals ETF | |||
RDTE | 33.39 | 0.28 | +0.85% |
Roundhill Russell 2000 0DTECovCllStgyETF | |||
TDVG | 43.71 | 0.27 | +0.63% |
T. Rowe Price Dividend Growth ETF | |||
NUAG | 21.27 | 0.02 | +0.12% |
Nuveen Enhanced Yield US Aggt Bd ETF | |||
KDRN | 23.27 | N/A | N/A |
Kingsbarn Tactical Bond ETF |